GRAFALON conc perf 100 mg/5ml flac 5 ml
7680524120014
CH-52412
L04AA04
07.15.0.
Reimbursement limitations:
GRAFALON.Kom
GRAFALON est utilisé en association avec d'autres médicaments immunosuppresseurs (p.ex. méthylprednisolone, prednisone, azathioprine, ciclosporine A) …
1 / 3
google
Details
- Product number
- 5241202
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- immunoglobulinum anti-T limphocytorum ex cuniculus 20 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Articles (1)
GRAFALON, Infusionslösungskonzentrat
Infusionslösungskonzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
20.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 421.45
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2025
Authorization holder
Neovii Pharmaceuticals AG
None Rapperswil-Jona
Authorization information
- Swissmedic authorization number
- 52412
- Drug name
- GRAFALON, Infusionslösungskonzentrat
- Galenic form
- LSPA
- ATC Code
- L04AA04
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 16/06/1994
- Authorization expiration date
- 31/12/9999
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- GRAFALON conc perf 100 mg/5ml flac 5 ml
- Description (DE)
- GRAFALON Inf Konz 100 mg/5ml Durchstf 5 ml
- Market launch
- 23/05/1996
- Narcotic (BTM)
- No
Application methods
IV